| IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS‐treated dendritic cells M Hill, S Tanguy‐Royer, P Royer, C Chauveau, K Asghar, L Tesson, ... European journal of immunology 37 (11), 3054-3062, 2007 | 190 | 2007 |
| Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2, 3-dioxygenase M Hill, V Pereira, C Chauveau, R Zagani, S Remy, L Tesson, D Mazal, ... The FASEB Journal 19 (14), 1957-1968, 2005 | 189 | 2005 |
| Role of inflammatory cytokines in depression: Focus on interleukin-1β RK Farooq, K Asghar, S Kanwal, A Zulqernain Biomedical reports 6 (1), 15-20, 2017 | 160 | 2017 |
| Bystander signaling via oxidative metabolism HA Sawal, K Asghar, M Bureik, N Jalal OncoTargets and therapy 10, 3925, 2017 | 44 | 2017 |
| Indoleamine 2, 3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan K Asghar, A Loya, IA Rana, M Tahseen, M Ishaq, A Farooq, MA Bakar, ... Cancer management and research 11, 475, 2019 | 36 | 2019 |
| Indoleamine 2, 3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma K Asghar, A Farooq, B Zulfiqar, MU Rashid World journal of gastroenterology 23 (13), 2286, 2017 | 33 | 2017 |
| Prevalence of TP53 germ line mutations in young Pakistani breast cancer patients MU Rashid, S Gull, K Asghar, N Muhammad, A Amin, U Hamann Familial cancer 11 (2), 307-311, 2012 | 27 | 2012 |
| Indoleamine 2, 3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis K Asghar, MT Ashiq, B Zulfiqar, A Mahroo, K Nasir, S Murad Experimental and therapeutic medicine 9 (3), 901-904, 2015 | 25 | 2015 |
| Nanomedicine and cancer immunotherapy: focus on indoleamine 2, 3-dioxygenase inhibitors B Zulfiqar, A Mahroo, K Nasir, RK Farooq, N Jalal, MU Rashid, K Asghar OncoTargets and therapy 10, 463, 2017 | 23 | 2017 |
| Structural and functional annotation of human FAM26F: a multifaceted protein having a critical role in the immune system U Malik, A Javed, A Ali, K Asghar Gene 597, 66-75, 2017 | 22 | 2017 |
| Potential role of indoleamine 2, 3‑dioxygenase in primary biliary cirrhosis K Asghar, J Brain, JM Palmer, S Douglass, F Naemi, G O'boyle, J Kirby, ... Oncology letters 14 (5), 5497-5504, 2017 | 18 | 2017 |
| Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives B Zulfiqar, A Farooq, S Kanwal, K Asghar Frontiers in Pharmacology 13, 2022 | 17 | 2022 |
| Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from Pakistan MU Rashid, S Gull, S Faisal, S Khaliq, K Asghar, N Siddiqui, A Amin, ... Familial cancer 10 (4), 709-712, 2011 | 9 | 2011 |
| Review of 10 years of research on breast cancer patients: Focus on indoleamine 2, 3-dioxygenase K Asghar, A Farooq, B Zulfiqar, A Loya World Journal of Clinical Oncology 12 (6), 429, 2021 | 7 | 2021 |
| Clinical characteristics of COVID-19-infected cancer patients in Pakistan: Differences between survivors and non-survivors K Asghar, M Abu Bakar, MJ Akram, A Farooq, K Siddique, IA Rana, J Ali, ... Frontiers in oncology 11, 655634, 2021 | 7 | 2021 |
| Association between Cyclooxygenase-2 and Indoleamine 2, 3-Dioxygenase Expression in Breast Cancer Patients from Pakistan K Asghar, A Loya, IA Rana, MA Bakar, A Farooq, M Tahseen, M Ishaq, ... Asian Pacific Journal of Cancer Prevention: APJCP 20 (11), 3521, 2019 | 7 | 2019 |
| Efficacy of Radioiodine Therapy in Patients With Primary Hyperthyroidism: An Institutional Review From Pakistan AM Alvi, U Azmat, W Shafiq, AHA Rasheed, AI Siddiqi, S Khan, S Ashfaq, ... Cureus 14 (5), 2022 | 3 | 2022 |
| Activity of indoleamine 2, 3 dioxygenase (IDO) in type 2 diabetes mellitus patients in Pakistan SH Hussain, SM Hussain, N Ikram, Y Badshah, K Asghar Journal of Rawalpindi Medical College 21 (2), 2017 | 3 | 2017 |
| Establishment of biobanking facility at Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan K Asghar, A Loya Cell and Tissue Banking 23 (4), 937-938, 2022 | 2 | 2022 |
| COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management K Asghar, MA Bakar, S Ashfaq, AM Alvi, W Shafiq, U Azmat, AI Siddiqi, ... Frontiers in Oncology 12, 2022 | 2 | 2022 |
Asim FarooqResearch Associate, Pakistan Kidney and Liver Institute and Research Center在 pkli.org.pk 的电子邮件经过验证
